Goods & Services

Pharmaceuticals, medical and veterinary preparations; vaccines; vaccine preparations; veterinary vaccines; veterinary preparations and substances; diagnostic preparations and materials, for medical and veterinary purposes. Veterinary services; information services relating to veterinary pharmaceuticals; veterinary analysis services for diagnostic or treatment purposes; information services relating to the veterinary pharmaceutical industry; veterinary advisory services; providing veterinary information.

Goods & Services

Pharmaceuticals, medical and veterinary preparations; vaccines; vaccine preparations; veterinary vaccines; veterinary preparations and substances; diagnostic preparations and materials, for medical and veterinary purposes. Veterinary services; information services relating to veterinary pharmaceuticals; veterinary analysis services for diagnostic or treatment purposes; information services relating to the veterinary pharmaceutical industry; veterinary advisory services; providing veterinary information.

Goods & Services

(1) Pharmaceuticals, medical and veterinary preparations; vaccines; vaccine preparations; veterinary vaccines; veterinary preparations and substances; diagnostic preparations and materials, for medical and veterinary purposes. (1) Veterinary services; information services relating to veterinary pharmaceuticals; veterinary analysis services for diagnostic or treatment purposes; information services relating to the veterinary pharmaceutical industry; veterinary advisory services; providing veterinary information.

Abstract

The present disclosure relates to immunogenic fusion polypeptides, immunogenic compositions and vaccine compositions comprising said fusion polypeptides and use thereof for immunization of mammals susceptible to Streptococcus suis infection. The disclosure also relates to methods for preparing, formulating and administrating such compositions.

IPC Classes  ?

• A61K 39/09 - Streptococcus
• A61P 37/04 - Immunostimulants
• C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci

Goods & Services

Pharmaceuticals, medical and veterinary preparations; Vaccines; Vaccine preparations; Veterinary vaccines; Veterinary preparations and substances; Diagnostic preparations and materials, for medical and veterinary purposes.. Veterinary services; Information services relating to veterinary pharmaceuticals; Veterinary analysis services for diagnostic or treatment purposes; Information services relating to the veterinary pharmaceutical industry; Veterinary advisory services; Providing veterinary information..

Abstract

Streptococcus suisStreptococcus suis infection. The disclosure also relates to methods for preparing, formulating and administrating such compositions.

IPC Classes  ?

• A61K 39/09 - Streptococcus
• A61K 39/00 - Medicinal preparations containing antigens or antibodies
• A61P 31/04 - Antibacterial agents
• C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci

Goods & Services

Veterinary preparations; Veterinary vaccines.

Abstract

Streptococcus suis infection. The disclosure also relates to methods for preparing, formulating and administrating such compositions.

IPC Classes  ?

• C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
• A61K 39/09 - Streptococcus
• A61P 31/04 - Antibacterial agents
• A61K 39/00 - Medicinal preparations containing antigens or antibodies

Abstract

Streptococcus suis infection. The disclosure also relates to methods for preparing, formulating and administrating such compositions.

IPC Classes  ?

• C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
• A61P 31/04 - Antibacterial agents
• A61K 39/09 - Streptococcus
• A61K 39/00 - Medicinal preparations containing antigens or antibodies

Abstract

The present disclosure relates to immunogenic polypeptides, immunogenic compositions and vaccine compositions and use thereof for immunization of mammals susceptible to Streptococcus suis infection. The disclosure also relates to methods for preparing, formulating and administrating such compositions.

IPC Classes  ?

• A61K 39/09 - Streptococcus
• C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
• A61K 39/00 - Medicinal preparations containing antigens or antibodies

Abstract

zooepidemicus. A vaccine composition comprising the antigenic composition as immunizing component is also disclosed.

IPC Classes  ?

• A61K 39/09 - Streptococcus
• C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
• C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
• A61K 31/7088 - Compounds having three or more nucleosides or nucleotides
• A61K 39/40 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum bacterial
• C07K 19/00 - Hybrid peptides
• A61K 39/00 - Medicinal preparations containing antigens or antibodies

Abstract

zooepidemicus. The present invention also discloses a vaccine composition comprising the aforesaid antigenic composition as immunizing component.

IPC Classes  ?

• A61K 39/09 - Streptococcus
• C12N 15/09 - Recombinant DNA-technology
• C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
• A61P 31/04 - Antibacterial agents
• C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
• A61K 39/00 - Medicinal preparations containing antigens or antibodies

Abstract

zooepidemicus. A vaccine composition comprising the antigenic composition as immunizing component is also disclosed.

IPC Classes  ?

• C07K 19/00 - Hybrid peptides
• A61K 39/09 - Streptococcus
• C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
• C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
• A61K 31/7088 - Compounds having three or more nucleosides or nucleotides
• A61K 39/40 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum bacterial
• A61K 39/00 - Medicinal preparations containing antigens or antibodies

Abstract

An antigenic composition comprises several antigenic components derived from antigens of Streptococcus equi subsp. equi or subsp. zooepidemicus, wherein at least one component is a fusion protein or polypeptide comprising two or more such antigens or fragments thereof. The antigenic composition may be used for immunization of mammals against S. equi subsp. equi and/or subsp. zooepidemicus. A vaccine composition comprising the antigenic composition as immunizing component is also disclosed.

IPC Classes  ?

• C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
• A61K 39/09 - Streptococcus
• A61K 39/40 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum bacterial
• A61K 31/04 - Nitro compounds
• C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
• C07K 19/00 - Hybrid peptides

Abstract

An antigenic composition comprises at least one antigen, wherein said at least one antigen comprises at least part of a protein selected from EndoSe of Streptococcus equi subsp. Equi, EndoSz of Streptococcus equi subsp. zooepidemicus, and Endo S of Streptococcus pyogenes, and wherein said at least part of said protein comprises at least one antigenic epitope. A vaccine composition comprising the antigenic composition as immunizing component, methods for producing the antigeninc composition and the vaccine composition, use of the vaccine composition for prophylactic and therapeutic treatment, and an antibody preparation comprising monoclonal or polyclonal antibodies specific for an antigen or antigens of the antigenic composition are also discosed.

IPC Classes  ?

• A61K 39/09 - Streptococcus

Abstract

The present invention is concerned with an antigenic composition comprising at least one antigen that comprises at least one antigenic epitope or antigenic determinant derived from a protein present in one or both of S. equi subsp. equi and subsp. zooepidemicus and use thereof for immunization of non-human mammals against S. equisubsp. equi and/or subsp. zooepidemicus.The present invention also discloses a vaccine composition comprising the aforesaid antigenic composition as immunizing component.

IPC Classes  ?

• A61K 39/09 - Streptococcus
• C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
• A61K 39/40 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum bacterial
• C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria

Goods & Services

Pharmaceutical and veterinary preparations, vaccines.

Abstract

Zooepidemicus. The present invention also discloses a vaccine composition comprising the aforesaid antigenic composition as immunizing component. The antigens used are EAG, FNZ, SFS, SEC and ScLC.

IPC Classes  ?

• A61K 39/09 - Streptococcus